91 related articles for article (PubMed ID: 1547225)
41. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
Grimm SW; Dyroff MC; Philpot RM; Halpert JR
Mol Pharmacol; 1994 Dec; 46(6):1090-9. PubMed ID: 7808429
[TBL] [Abstract][Full Text] [Related]
42. Sequence requirements for cytochromes P450IIA1 and P450IIA2 catalytic activity: evidence for both specific and non-specific substrate binding interactions through use of chimeric cDNAs and cDNA expression.
Hanioka N; Korzekwa K; Gonzalez FJ
Protein Eng; 1990 Jul; 3(7):571-5. PubMed ID: 2217131
[TBL] [Abstract][Full Text] [Related]
43. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
Aoyama T; Korzekwa K; Matsunaga T; Nagata K; Gillette J; Gelboin HV; Gonzalez FJ
Drug Metab Dispos; 1990; 18(3):378-82. PubMed ID: 1974203
[TBL] [Abstract][Full Text] [Related]
44. Selective interactions of cytochromes P-450 with the hydroxymethyl derivatives of 7,12-dimethylbenz[a]anthracene.
Christou M; Marcus C; Jefcoate CR
Carcinogenesis; 1986 Jun; 7(6):871-7. PubMed ID: 3085967
[TBL] [Abstract][Full Text] [Related]
45. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
46. Expression of truncated forms of liver microsomal P450 cytochromes 2B4 and 2E1 in Escherichia coli: influence of NH2-terminal region on localization in cytosol and membranes.
Pernecky SJ; Larson JR; Philpot RM; Coon MJ
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2651-5. PubMed ID: 8464872
[TBL] [Abstract][Full Text] [Related]
47. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
[TBL] [Abstract][Full Text] [Related]
48. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
49. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
50. Catalytic Reaction of Basidiomycete Lentinula edodes Cytochrome P450, Le.CYP1 Enzyme Produced in Yeast.
Akiyama R; Kajiwara S; Shishido K
Biosci Biotechnol Biochem; 2004 Jan; 68(1):79-84. PubMed ID: 14745167
[TBL] [Abstract][Full Text] [Related]
51. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.
Ono S; Hatanaka T; Hotta H; Satoh T; Gonzalez FJ; Tsutsui M
Xenobiotica; 1996 Jul; 26(7):681-93. PubMed ID: 8819299
[TBL] [Abstract][Full Text] [Related]
52. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
[TBL] [Abstract][Full Text] [Related]
53. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
54. Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes.
Maltzman TH; Christou M; Gould MN; Jefcoate CR
Carcinogenesis; 1991 Nov; 12(11):2081-7. PubMed ID: 1934293
[TBL] [Abstract][Full Text] [Related]
55. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
[TBL] [Abstract][Full Text] [Related]
56. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
Chang TK; Chen H; Waxman DJ
Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
[TBL] [Abstract][Full Text] [Related]
57. Metabolism of polycyclic aromatic hydrocarbons and covalent binding of metabolites to protein in rat adrenal gland.
Montelius J; Papadopoulos D; Bengtsson M; Rydström J
Cancer Res; 1982 Apr; 42(4):1479-86. PubMed ID: 6800653
[TBL] [Abstract][Full Text] [Related]
58. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae.
Brian WR; Sari MA; Iwasaki M; Shimada T; Kaminsky LS; Guengerich FP
Biochemistry; 1990 Dec; 29(51):11280-92. PubMed ID: 2271712
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2.
Pottenger LH; Jefcoate CR
Carcinogenesis; 1990 Feb; 11(2):321-7. PubMed ID: 2154339
[TBL] [Abstract][Full Text] [Related]
60. The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene on the expression of PAH activating enzymes and its modulation by plant phenols.
Szaefer H; Krajka-Kuźniak V; Baer-Dubowska W
Toxicology; 2008 Sep; 251(1-3):28-34. PubMed ID: 18694800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
